治験イメージング市場 | サイズ分析・成長・展望 (2022-2030)

Table of Content

1.Introduction

1.1.Market Introduction
1.2.Market Research Methodology
1.2.1.Research Process
1.2.2.Primary Research
1.2.3.Secondary Research
1.2.4.Data Collection Technique
1.2.5.Data Sources
1.3.Market Estimation Methodology
1.3.1.Limitations of the Study
1.4.Product Picture of Clinical Trial Imaging
1.5.Global Clinical Trial Imaging Market: Classification
1.6.Geographic Scope
1.7.Years Considered for the Study
1.8.Research Methodology in Brief
1.9.Parent Market Overview
1.10. Clinical Trial Imaging Market Regional Demand
1.11. Research Programs/Design
1.12. Market Breakdown and Data Triangulation Approach
1.13. Data Source
1.14. Secondary Sources
1.15. Primary Sources
1.16. Primary Interviews
1.17. Average Primary Breakdown Ratio

2.Market Dynamics

2.1.Drivers
2.1.1.Drivers
2.2.Restraints
2.2.1.Restraints
2.3.Opportunity
2.3.1.Impact Forces on Market Dynamics
2.3.2.Impact Forces During the Forecast Years
2.4.Industry Value Chain
2.4.1.Upstream Analysis
2.4.2.Downstream Analysis
2.4.3.Distribution Channel
2.4.4.Direct Channel
2.4.5.Indirect Channel
2.5.Potential Customers
2.6.Manufacturing/Operational Cost Analysis
2.7.Pricing Analysis by Region
2.8.Key Technology Landscape
2.9.Porter\'s Analysis
2.9.1.Supplier Power
2.9.2.Buyer Power
2.9.3.Substitution Threat
2.9.4.Threat from New Entry
2.9.5.Competitive Rivalry
2.10. PESTEL Analysis
2.10.1. Political Factors
2.10.2. Economic Factors
2.10.3. Social Factors
2.10.4. Technological Factors
2.10.5. Environmental Factors
2.10.6. Legal Factors

3.Global Clinical Trial Imaging Market Segmentation, by Revenue (USD Million), (2023-2030)

3.1.By Product and Services Type
3.1.1.Services
3.1.2.Software
3.2.By Modality
3.2.1.X-rays
3.2.2.CT (Computed Tomography)
3.2.3.MRI (Magnetic Resonance Imaging)
3.2.4.Ultrasound
3.2.5.PET
3.2.6.Others
3.3.By Application
3.3.1.Oncology
3.3.2.Neurology
3.3.3.Endocrinology
3.3.4.Cardiology
3.3.5.Dermatology
3.3.6.Hematology
3.3.7.Others
3.4.By End User
3.4.1.Pharmaceutical & Biotechnology Companies
3.4.2.Contract Research Organizations
3.4.3.Medical Device Manufacturers
3.4.4.Academic and Government Research Institute
3.4.5.Others

4.Global Clinical Trial Imaging Market Overview, By Region

4.1. North America Clinical Trial Imaging Market Revenue (USD Million), by Countries, (2023-2030)
4.1.1. U.S.
4.1.1.1.By Product and Services
4.1.1.2.By Modality
4.1.1.3.By Application
4.1.1.4.By End User
4.1.2.Canada
4.1.3.Mexico
4.2.Europe Clinical Trial Imaging Market Revenue (USD Million), by Countries, (2023-2030)
4.2.1.Germany
4.2.2.France
4.2.3.UK
4.2.4.Spain
4.2.5.Russia
4.2.6.Italy
4.2.7.BENELUX
4.3.Asia Pacific Clinical Trial Imaging Market Revenue (USD Million), by Countries, (2023-2030)
4.3.1. China
4.3.2. Japan
4.3.3. Australia
4.3.4. South Korea
4.3.5. India
4.3.6. ASEAN
4.4.Latin America Clinical Trial Imaging Market Revenue (USD Million), by Countries, (2023-2030)
4.4.1. Brazil
4.4.2. Argentina
4.4.3. Chile
4.5.Middle East and Africa Clinical Trial Imaging Market Revenue (USD Million), by Countries, (2023-2030)
4.5.1.GCC
4.5.2.Turkey
4.5.3.South Africa

5.Global Clinical Trial Imaging Market Revenue: Competitive Analysis, 2022

5.1.Key Strategies by Players
5.2.Revenue (USD Million) and Market Share (%), By Manufacturers, 2022
5.3.Player Positioning by Market Players, 2022

6.Competitive Analysis

6.1.Clario.
6.1.1.Business Overview
6.1.2.Business Financials (USD Million)
6.1.3.Product Category, Type, and Specification
6.1.4.Main Business/Business Overview
6.1.5.Geographical Analysis
6.1.6.Recent Development
6.1.7.SWOT Analysis
6.2.Biomedical Systems Corporation
6.3.Biotelemetry, Inc,
6.4.Image Core Lab
6.5.WCG Clinical
6.6.Ixico PLC
6.7.Resonance Health Limited
6.8.Medspace Holdings Inc.
6.9.Median Technologies
6.10.Radiant Sage

7.Market Research Findings & Conclusion

Disclaimer